SPRY
ARS Pharmaceuticals, Inc. · Healthcare
10% owner James E Flynn sold $10.1M of ARS Pharmaceuticals, Inc.
Sold$10,143,706
$18.01Price
563,270Shares
−5%Stake
What SPRY did after the filing
- The stock from Thu, Nov 14 open, $14.51
- −26.8%
- S&P 500, same days
- −1.2%
Measured over 30 trading days, to the Dec 30 close.
Traded Mon, Nov 11. Filed Wed, Nov 13, 8:16 PM ET, after the close. Returns use the Nov 14 open and the Dec 30 close. Not investment advice.